crossover design when use RSABE with two test products [Design Issues]

posted by Darborn – Taiwan, 2023-08-22 04:24 (1030 d 01:05 ago) – Posting: # 23704
Views: 9,177

Dear all,

Normally we use 2x3x3 or 2x2x4 replicated design for RSABE, but it needs only one test drug.
When design a crossover trial with two test drug (or one ODT given with/without water), I run into confusion about how to give a balanced design for the trial.
Furthermore, which make things even worse, I always get confused by "variance-balanced" and "carryover-balance" design.

I came out with the following design, but I'm not sure if it is suitable to use when analyzed with FDA RSABE approach.

T1  R   T2   R
R   T1  R   T2
T2  R   T1  R
R   T2  R   T1


Thank you!
Darborn


Edit: Tabulators changed to spaces and BBcoded; see also this post #6[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
181 visitors (0 registered, 181 guests [including 68 identified bots]).
Forum time: 05:30 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5